← Back

Nygen 🇸🇪

Seed

AI-native single-cell omics analysis platform with reasoning engine for cell identity and drug discovery. Lund.

About Nygen

Nygen offers an AI-native platform for single-cell omics that enhances traditional analysis by providing deeper insights and clearer interpretations of single-cell data. Its technology includes a structured AI reasoning engine for cell identity assignment, a collaborative analysis interface, and a distributed infrastructure for secondary analysis, all designed to improve the identification of biologically relevant signals and support drug discovery efforts.

Nygen is a Sweden-based company founded in 2021, now around 8 people. FundFinder classes it as AI & ML.

Founded by Parashar Dhapola (Chief Executive Officer; previously IGIB; Lund University), Oskar Börjesson Stenström (Co-Founder and Head of Engineering; previously Apple, Axis Communications; The Faculty of Engineering At Lund University).

Its investors also appear on FundFinder's most-active lists for Seed · Generalist (110 funds), Seed · AI (93 funds), Seed · DeepTech (80 funds).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on Nygen? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Seed · Nov 2025

InvestorsAlmi Invest
  • Almi Invest — Almi Invest is the state-owned Swedish venture investor within the Almi Group and calls itself Sweden's most active startup investor. · cheques £75k – £300k
Raising your own round? See which European funds fit →